Universal Influenza Vaccine Technology Landscape

The Landscape is a database of novel vaccine candidates designed to provide broader and more durable protection against circulating and pandemic influenza viruses, compared with current strain-specific seasonal influenza vaccines. CIDRAP is developing the landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development.

Tracker

Vaccine Candidates 159 Vaccine Candidates
Vaccine in clinical trials 28 Vaccines in Clinical Trials
Developers 128 Developers
Platforms 6 Platforms
Preclinical 131
Phase 1 17
Phase 2 6
Phase 3 5
Approved 0

Database

Previous Next
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Platform

Recombinant proteins

34
Vaccines in
Preclinical
2
Vaccines in
Phase 1
1
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Recombinant influenza virus-based

11
Vaccines in
Preclinical
4
Vaccines in
Phase 1
1
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Virus-vectored

21
Vaccines in
Preclinical
2
Vaccines in
Phase 1
3
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Virus-like particles (VLP)

22
Vaccines in
Preclinical
2
Vaccines in
Phase 1
0
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Non-VLP nanoparticles

24
Vaccines in
Preclinical
3
Vaccines in
Phase 1
1
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved